STAT

JULY 5, 2024

New research finds that the GLP-1 class of drugs — glucagon-like peptide receptor agonists — is more effective in mitigating the risk of 10 obesity-associated cancers than its type 2 diabetes drug alternatives. The retrospective study, published Friday in JAMA Network Open , measured results for a cohort of more than 1.6 million patients with type 2 diabetes from 2005 to 2018 who were prescribed GLP-1s, insulin, or metformin.

143

143

pharmaphorum

JULY 5, 2024

Discover how innovative approaches and specialised expertise in peptide API synthesis are increasing efficiency and driving advancements in the manufacturing of Active Pharmaceutical Ingredients (API).

116

116

STAT

JULY 5, 2024

WASHINGTON — Pharmaceutical giant AbbVie paid health care providers roughly $145.7 million last year to promote its drugs, according to a STAT analysis of newly released government data. The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceutical company has spent on marketing to doctors since such data became available in 2017.

Pharmaceutical Companies 126

Pharmaceutical Companies Pharmaceutical Companies Hospitals 126

pharmaphorum

JULY 5, 2024

Explore the vital partnerships and people involved in shaping Labour's policies on the NHS, healthcare, and life sciences during the general election. Learn more about the key areas of focus and priorities.

113

113

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 5, 2024

WASHINGTON — A federal judge ruled against Boehringer Ingelheim’s challenge to the new Medicare drug price negotiation program, handing the pharmaceutical industry its latest in a string of legal losses. The company had argued before the U.S. District Court of Connecticut that the drug pricing law was unconstitutional under four different parts of the Constitution, and also that Medicare officials had violated procedural laws.

119

119

pharmaphorum

JULY 5, 2024

Learn about Professor Melanie Bailey's research on single-cell multi-omics and its oncological potential through the company SEISMIC. Discover the groundbreaking work and contributions to the field.

103

103

pharmaphorum

JULY 5, 2024

Reports indicate that private equity firms Bain Capital and Cinven may be contemplating a bid for the consumer health division of Sanofi.

111

111

STAT

JULY 5, 2024

One night in November 2018, I fell while crossing a street in Subic Bay, a U.S. naval logistics station in The Philippines. My face whacked the asphalt. Lying in the path of oncoming traffic, I couldn’t move a muscle. After 45 seconds of terror, I was able to stand up and haul myself to the other side. Six months later, after dealing with symptoms like my left leg buckling unexpectedly and being extra tired hauling my tools around on the job, a doctor told me I had amyotrophic lateral scl

FDA 143

FDA 143

Pharmacy Times

JULY 5, 2024

Pharmacists can play a crucial role in diabetes management by implementing standing order protocols for medication titration and serving as a bridge between patients and other health care providers.

Patient Care 94

Patient Care 94

Outsourcing Pharma

JULY 5, 2024

Meg Wilkinson, a resilient cancer survivor, recently sat down with OSP editor Liza Laws to discuss her journey from diagnosis to founding the Omentum Project.

98

98

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

JULY 5, 2024

After Labour landslide in UK general election, former shadow health secretary West Streeting sets out his objectives for the NHS.

105

105

Pharmacy Times

JULY 5, 2024

Vitamin D could mitigate negative impacts on neurobehavior and weight gain caused by consumption of monosodium glutamate (MSG).

138

138

Pharmaceutical Technology

JULY 5, 2024

Fucaso, a BCMA CAR T-cell therapy, is co-developed by Innovent and IASO Bio and was approved to treat multiple myeloma in China last month.

97

97

Pharmacy Times

JULY 5, 2024

Alan Chin, PharmD, BCOP, presents an overview of the most prevalent and common adverse reactions associated with EGFR-targeted therapies in metastatic NSCLC and shares strategies to mitigate toxicities, with a focus on managing dermatologic events such as rash and itching.

Adverse Reactions 65

Adverse Reactions 65

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmaceutical Technology

JULY 5, 2024

Approval is based on positive data from the Phase III FLAURA2 trial where Tagrisso plus chemotherapy showed PFS of 24.4 months.

Chemotherapy 98

Chemotherapy 98

Pharmacy Times

JULY 5, 2024

A pharmacy expert explores infusion-related reactions associated with amivantamab, providing guidance on managing and preventing these reactions, while also addressing the role of split-dosing, premedications, and steroids in the treatment paradigm.

65

65

Oswald's

JULY 5, 2024

If you’re a regular prescription customer here at Oswald’s, you’ve definitely seen our antique display case of relics from our 149-year history. They include nametags of both my great-grandparents Harold… The post A Message From Alex July 2024 appeared first on Oswald's Pharmacy.

52

52

DiversifyRx

JULY 5, 2024

Elevate Your Pharmacy: The Power of Preparation Preparation is the only way to make your pharmacy a success. The only way to be certain of the future is to create it. As independent pharmacy owners, we know how crucial it is to stay ahead of the game. The independent pharmacy landscape is always evolving, and our ability to adapt and excel can be the difference between thriving or barely surviving.

Independent Pharmacies 52

Independent Pharmacies Customer Service Vaccines Patient Care 52

Pharmaceutical Technology

JULY 5, 2024

HF-158K1 is under clinical development by HighField Biopharmaceuticals and currently in Phase I for Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer (HER2+ Breast Cancer).

52

52

PharmExec

JULY 5, 2024

In an interview with Pharm Exec Associate Editor Don Tracy, Kathy Lee-Sepsick, Founder, CEO, Femasys, offers a description of how Femaseed works to support women who struggle with infertility.

52

52

Pharmaceutical Technology

JULY 5, 2024

BioSenic and Medsenic filed patent application with the USPTO to extend the protection for the use of arsenic trioxide (ATO) for sepsis.

59

59

Pharmacy Times

JULY 5, 2024

In 2 different dose groups, the majority of patients with eosinophilic esophagitis aged 1 to 11 achieved histologic remission at week 16 compared with patients treated with placebo.

50

50

Pharmaceutical Technology

JULY 5, 2024

The UK life science industry is crossing its fingers as a Labour government takes the reigns following 14 years of Conservative rule.

59

59

PharmExec

JULY 5, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

FDA 52

FDA 52

Pharmaceutical Technology

JULY 5, 2024

Whilst Regeneron and Sanofi secured approval in Europe for COPD, the FDA has delayed Dupixent’s application review for the disease in the US.

FDA 52

FDA 52

Pharmaceutical Commerce

JULY 5, 2024

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

52

52

Pharmaceutical Technology

JULY 5, 2024

The EMA has validated Philogen and Sun Pharmaceutical’s marketing authorisation application (MAA) for Nidlegy, a treatment for melanoma.

52

52

Pharmaceutical Commerce

JULY 5, 2024

An observational, retrospective cohort study undergoes this investigation in individuals 24 years of age or older.

52

52

Pharmaceutical Technology

JULY 5, 2024

Pendopharm has signed a distribution agreement with Ascendis Pharma to bring the hypoparathyroidism treatment, TransCon PTH, to Canada.

52

52

Pharmacy Times

JULY 5, 2024

The ACIP recommendations are designed to improve access to RSV vaccination, emphasizing the need to get vaccinated.

Vaccines 50

Vaccines 50

Pharmaceutical Technology

JULY 5, 2024

The UK took to the polls on 4 July 2024 and voted in a new government. How will a Labour government look for the clinical trial sector?

52

52

Pharma Times

JULY 5, 2024

The neurodegenerative disease currently affects more than 200,000 people worldwide

57

57

Pharmaceutical Technology

JULY 5, 2024

LP-184 is under clinical development by Starlight Therapeutics and currently in Phase I for Triple-Negative Breast Cancer (TNBC).

52

52

Pharmaceutical Commerce

JULY 5, 2024

The latest news for pharma industry insiders.

FDA 52

FDA 52